SCHEMBL29901816

SCHEMBL29901816

CC(C)(C)NS(=O)(=O)c1ccc(NC2CCCCC2)c(-c2nnn(CCO)n2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.41
▸ MAPT P10636 2/20 0.41
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ HPGD P15428 2/20 0.38
▸ THRB P10828 1/20 0.38
▸ LMNA P02545 5/20 0.38
▸ GLA P06280 1/20 0.38
▸ BRD4 O60885 1/20 0.37
▸ CHEK1 O14757 1/20 0.36
▸ NTRK1 P04629 1/20 0.36
▸ MET P08581 1/20 0.36
▸ PIM1 P11309 1/20 0.36
▸ LTK P29376 1/20 0.36
▸ GRK5 P34947 1/20 0.36
▸ MAP2K2 P36507 1/20 0.36
▸ CDK8 P49336 1/20 0.36
▸ NEK2 P51955 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20766211 1.00 ALDH1A1 (0.41) ALDH1A1MAPTCYP3A4CYP2D6CYP2C9
SCHEMBL20766225 0.90 ALDH1A1 (0.42) ALDH1A1MAPTHPGDTHRBLMNA
SCHEMBL20766234 0.81 ALDH1A1 (0.43) ALDH1A1MAPTHPGDTHRBLMNA
SCHEMBL20766378 0.81 ALDH1A1 (0.50) ALDH1A1MAPTHPGDTHRBLMNA
SCHEMBL20766607 0.81 ALDH1A1 (0.40) ALDH1A1MAPTHPGDTHRBLMNA
SCHEMBL20767215 0.80 ALDH1A1 (0.42) ALDH1A1MAPTHPGDTHRBLMNA
SCHEMBL20767259 0.78 ALDH1A1 (0.40) ALDH1A1MAPTHPGDTHRBLMNA
SCHEMBL20779653 0.78 ALOX15 (0.46) ALDH1A1MAPTHPGDTHRBLMNA
SCHEMBL20766200 0.77 MAPT (0.40) ALDH1A1MAPTHPGDTHRBLMNA
SCHEMBL25789400 0.77 CNR1 (0.42) ALDH1A1MAPTCYP3A4HPGDTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3691623-B1 BENZOSULFONYL COMPOUNDS VIVACE THERAPEUTICS INC (US) 2022-10-05 — — EP disclosed
Send feedback